| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699651 | Clinical Oncology | 2009 | 7 Pages |
Abstract
Population-based incidences of SMD requiring local treatment have been reported for the first time. The prevalence of MSCC at the time of cancer diagnosis was higher than previously reported. A more precise definition of MSCC and more population-based studies are needed to reduce selection bias when comparing different studies.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
O. Zaikova, K.-E. Giercksky, S.D. Fosså, S. Kvaløy, T.B. Johannesen, S. Skjeldal,